Paradoxical Effects of Plant-Originated Antioxidants on Hyperlipidemia: A Review

Document Type : Review Paper

Authors

1 Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran

2 LMCC, Independent Research, Toronto, Canada

3 Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Antioxidants protect the body's organs, but under certain conditions, they may increase oxidative stress and potentially induce organ damage. High-density lipoprotein (HDL) helps prevent cardiovascular disease by reducing oxidative stress and Low-density lipoprotein (LDL) oxidation. Although lipid oxidation contributes to atherosclerosis and antioxidants are generally beneficial, their exact impact remains unclear. A close relationship exists between medicinal plants and antioxidants, as many medicinal plants contain antioxidant compounds that can contribute to the health of the body. Medicinal plants are a class of plants that naturally contain various types of antioxidants. A number of antioxidant compounds have been identified in medicinal plants, including polyphenols, flavonoids, tannins, vitamins C and E. This review updates the recent findings and action mechanisms of antioxidants, focusing on the positive and negative roles of antioxidants in atherosclerosis with the aim of clarifying the knowledge gap. This article reviews the publications from 1991 to 2025 sourced from Google Scholar, PubMed, Web of Science, and Scopus, using terms such as Antioxidants, oxidative stress, free radicals, hyperlipidemia, lipid profile, and inflammation. The study updates the effects of Beta-carotene, Lutein, Quercetin, Silymarin, Betaine, Carotenoids, Lycopene, Flavonoids, Vitamins A, D, E, Selenium, Coenzyme Q10, and Epicatechin on blood lipids. Reactive oxygen species (ROS) contribute to heart diseases and hyperlipidemia. Antioxidants neutralize ROS and reduce oxidative stress, but the circumstances under which they may act as prooxidants should be considered in atherosclerosis therapy.

Keywords

Main Subjects


  1. Pansooksan K., Chailom C., Kaewpaeng N., Pisutthanan S., Rittaisong N., Yau L., Pekthong D., Srisawang P., Nakaew N., Parhira S. Phytochemical profiling, antioxidant potential, and anti-Acinetobacter baumannii activity of Macadamia integrifolia Maiden & Betche shell extracts. Journal of Herbmed Pharmacology. 2025;14(3):339-47.
  2. Berdja S., Boudarene L., Smail L., Neggazi S., Boumaza S., Sahraoui A., Haffaf E.-M., Kacimi G., Aouichat Bouguerra S. Scolymus hispanicus (golden thistle) ameliorates hepatic steatosis and metabolic syndrome by reducing lipid accumulation, oxidative stress, and inflammation in rats under hyperfatty diet. Evidence-Based Complementary and Alternative Medicine. 2021;2021:5588382.
  3. Afkhami-Ardekani M., Shojaoddiny-Ardekani A. Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients. Indian Journal of Medical Research. 2007;126(5):471-74.
  4. Kwan B.C., Kronenberg F., Beddhu S., Cheung A.K. Lipoprotein metabolism and lipid management in chronic kidney disease. Journal of the American Society of Nephrology. 2007;18(4):1246-61.
  5. Papas A.M. Antioxidant status, diet, nutrition, and health. CRC Press. 2019.
  6. Young I., Woodside J. Antioxidants in health and disease. Journal of Clinical Pathology. 2001;54(3):176-86.
  7. Dhammaraj T., Lamlong C., Sriputthatham S., Saentaweesuk W., Wichai N. Total flavonoid and phenolic contents, xanthine oxidase inhibition, antioxidant and anti-inflammatory activities of ethanolic and aqueous extracts of the Ya-Tom-Kae-Ka-Sai-Sen remedy, a traditional Thai medicine. Journal of Herbmed Pharmacology. 2025;14(4):504-13.
  8. Golafshan F., Shafieyoon M. Hypertension and chronic kidney disease; a mutual relationship. Journal of Renal Injury Prevention. 2024;13(3):e32277-e77.
  9. El-Din S.B., ALfiky H.A.A.A., Wahsh E., Badawy H., Seliem N., El Attar S., Mehanna M.G., Farahat A.M.A., Ibrahim M.M., Hafiz W.F.A. Effect of garlic on sodium fluoride-induced hypertension and elevated cardiac enzymes in male albino rats. Immunopathologia Persa. 2025;11(2):e43763-e63.
  10. Dhammaraj T., Kotseekieo P., Chotikarn T., Phosrithong N., Praison W., Prasomsub T., Lumthong P., Supaporn W., Sungthong B., Mudjupa C. In vitro investigation of xanthine oxidase inhibitory and antioxidant activities of 3,4,5-trihydroxycinnamic acid. Journal of Herbmed Pharmacology. 2024;13(3):439-49.
  11. Alsharairi N.A. The effects of dietary supplements on asthma and lung cancer risk in smokers and non-smokers: a review of the literature. Nutrients. 2019;11(4):725.
  12. Potestio L., Scalvenzi M., Lallas A., Martora F., Guerriero L., Fornaro L., Marano L., Villani A. Efficacy and safety of cemiplimab for the management of non-melanoma skin cancer: a drug safety evaluation. Cancers. 2024;16(9):1732.
  13. Garfinkel A.C., Seidman J.G., Seidman C.E. Genetic pathogenesis of hypertrophic and dilated cardiomyopathy. Heart Failure Clinics. 2018;14(2):139-46.
  14. Unsal V., Cicek M., Sabancilar İ. Toxicity of carbon tetrachloride, free radicals and role of antioxidants. Reviews on Environmental Health. 2021;36(2):279-95.
  15. Duc M.P., Nguyen K.X., Viet T.T., Le T.D., Nguyen N.P.T., Nguyen N.M., Cong T.L., Nguyen S.T., Van Nguyen B., Van Nguyen A. The association between urinary albumin excretion and nutrient status in patients with type 2 diabetes mellitus. Journal of Renal Injury Prevention. 2024;14(1):e32179-e79.
  16. Amarowicz R., Pegg R.B. Protection of natural antioxidants against low-density lipoprotein oxidation. Advances in Food and Nutrition Research. 2020;93:251-91.
  17. Miyashita R., Ugajin A., Oda H., Ozaki K. Identification and in vivo functional analysis of furanocoumarin-responsive cytochrome P450s in a Rutaceae-feeding Papilio butterfly. Journal of Experimental Biology. 2024;227(16):jeb262784.
  18. Indra Gumay Y. Kajian Penggunaan Onggok Tapioka yang Difermentasi sebagai Bahan Pakan Benih Ikan Patin (Pangasius hyphopthalmus). 2010.
  19. Alaei M., Hashemi M.G., Chatrnour G., Yaseri A.F. The importance of screening for hypertension in children and adolescents. Journal of Nephropathology. 2023;12(4):e14-e14.
  20. Pari S.M., Memarian M., Eskandarian R. Antioxidant therapy for hypertension; a mini-review on the recent findings. Journal of Nephropharmacology. 2024;13(2):e12694-e94
  21. Marcelino G., Machate D.J., Freitas K.d.C., Hiane P.A., Maldonade I.R., Pott A., Asato M.A., Candido C.J., Guimarães R.d.C.A. β-Carotene: Preventive role for type 2 diabetes mellitus and obesity: a review. Molecules. 2020;25(24):5803.
  22. Rodriguez-Concepcion M., Avalos J., Bonet M.L., Boronat A., Gomez-Gomez L., Hornero-Mendez D., Limon M.C., Meléndez-Martínez A.J., Olmedilla-Alonso B., Palou A. A global perspective on carotenoids: metabolism, biotechnology, and benefits for nutrition and health. Progress in Lipid Research. 2018;70:62-93.
  23. Lin W.T., Huang C.C., Lin T.J., Chen J.R., Shieh M.J., Peng H.C., Yang S.C., Huang C.Y. Effects of β-carotene on antioxidant status in rats with chronic alcohol consumption. Cell Biochemistry and Function. 2009;27(6):344-50.
  24. Yang S.-C., Huang C.-C., Chu J.-S., Chen J.-R. Effects of β-carotene on cell viability and antioxidant status of hepatocytes from chronically ethanol-fed rats. British Journal of Nutrition. 2004;92(2):209-15.
  25. Peng H.C., Chen J.R., Chen Y.L., Yang S.C., Yang S.S. β-Carotene exhibits antioxidant and anti-apoptotic properties to prevent ethanol-induced cytotoxicity in isolated rat hepatocytes. Phytotherapy Research. 2010;24(S2):S183-S89.
  26. Yun J.-W., Kim Y.-K., Lee B.-S., Kim C.-W., Hyun J.-S., Baik J.-H., Kim J.-J., Kim B.-H. Effect of dietary epigallocatechin-3-gallate on cytochrome P450 2E1-dependent alcoholic liver damage: enhancement of fatty acid oxidation. Bioscience, Biotechnology, and Biochemistry. 2007;71(12):2999-3006.
  27. Ajmo J.M., Liang X., Rogers C.Q., Pennock B., You M. Resveratrol alleviates alcoholic fatty liver in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2008;295(4):G833-G42.
  28. Terao J. Revisiting carotenoids as dietary antioxidants for human health and disease prevention. Food & Function. 2023;14(17):7799-824.
  29. Burton G.W., Ingold K. β-Carotene: an unusual type of lipid antioxidant. Science. 1984;224(4649):569-73.
  30. Han H., Cui W., Wang L., Xiong Y., Liu L., Sun X., Hao L. Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression. Lipids. 2015;50:261-73.
  31. Kim J.E., Leite J.O., DeOgburn R., Smyth J.A., Clark R.M., Fernandez M.L. A lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs. The Journal of Nutrition. 2011;141(8):1458-63.
  32. Renzi L.M., Hammond B.R., Dengler M., Roberts R. The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs. Lipids in Health and Disease. 2012;11:1-10.
  33. Martin K., Wu D., Meydani M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis. 2000;150(2):265-74.
  34. Armoza A., Haim Y., Basiri A., Wolak T., Paran E. Tomato extract and the carotenoids lycopene and lutein improve endothelial function and attenuate inflammatory NF-κB signaling in endothelial cells. Journal of Hypertension. 2013;31(3):521-29.
  35. Chung R.W., Leanderson P., Lundberg A.K., Jonasson L. Lutein exerts anti-inflammatory effects in patients with coronary artery disease. Atherosclerosis. 2017;262:87-93.
  36. Hajizadeh-Sharafabad F., Ghoreishi Z., Maleki V., Tarighat-Esfanjani A. Mechanistic insights into the effect of lutein on atherosclerosis, vascular dysfunction, and related risk factors: a systematic review of in vivo, ex vivo and in vitro studies. Pharmacological Research. 2019;149:104477.
  37. Dulal K., Ojha-Khatri S., Paudel H.R., Paudel M.R. In-vitro antioxidant and antidiabetic potential of Ephedra gerardiana stem extract. Journal of Herbmed Pharmacology. 2025;14(2):259-64.
  38. Rusli R., Ramadhan D.S.F., Rusdiaman R., Fakih T.M. Evaluating quercetin analogs from Indonesian bioflavonoids for breast cancer: insights from in silico and cytotoxicity assays. Journal of Herbmed Pharmacology. 2025;14(4):417-25.
  39. Molina M.F., Sanchez-Reus I., Iglesias I., Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biological and Pharmaceutical Bulletin. 2003;26(10):1398-402.
  40. Sanjari S., Shobbar Z.S., Ebrahimi M., Hasanloo T., Sadat-Noori S.-A., Tirnaz S. Chalcone synthase genes from milk thistle (Silybum marianum): isolation and expression analysis. Journal of Genetics. 2015;94:611-17.
  41. Song Z., Deaciuc I., Song M., Lee D.Y.W., Liu Y., Ji X., McClain C. Silymarin protects against acute ethanol-induced hepatotoxicity in mice. Alcoholism: Clinical and Experimental Research. 2006;30(3):407-13.
  42. Habib-ur-Rehman M., Mahmood T., Salim T., Afzal N., Ali N., Iqbal J., Tahir M., Khan A. Effect of silymarin on serum levels of ALT and GGT in ethanol induced hepatotoxicity in albino rats. Journal of Ayub Medical College Abbottabad. 2009;21(4):73-75.
  43. Lieber C.S., Leo M.A., Cao Q., Ren C., DeCarli L.M. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. Journal of Clinical Gastroenterology. 2003;37(4):336-39.
  44. Valenzuela A., Garrido A. Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin. Biological Research. 1994;27:105-15.
  45. Comoglio A., Tomasi A., Malandrino S., Poli G., Albano E. Scavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicals. Biochemical Pharmacology. 1995;50(8):1313-16.
  46. Brandon-Warner E., Sugg J.A., Schrum L.W., McKillop I.H. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Letters. 2010;291(1):120-29.
  47. Razavi B.M., Karimi G. Protective effect of silymarin against chemical-induced cardiotoxicity. Iranian Journal of Basic Medical Sciences. 2016;19(9):916-24.
  48. Jin D., Yang R., Piao J., Ji Y., Li S. First report of Beet Western Yellows Virus infecting wheat in China. Plant Disease. 2023;107(8):2565.
  49. Kanbak G., İnal M., Bayçu C. Ethanol-induced hepatotoxicity and protective effect of betaine. Cell Biochemistry and Function. 2001;19(4):281-85.
  50. Ji C., Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology. 2003;124(5):1488-99.
  51. Balkan J., Öztezcan S., Küçük M., Çevikbaş U., Koçak-Toker N., Uysal M. The effect of betaine treatment on triglyceride levels and oxidative stress in the liver of ethanol-treated guinea pigs. Experimental and Toxicologic Pathology. 2004;55(6):505-09.

 

  1. Antoine J.M., Fung L.A.H., Grant C.N. Assessment of the potential health risks associated with the aluminium, arsenic, cadmium and lead content in selected fruits and vegetables grown in Jamaica. Toxicology Reports. 2017;4:181-87.
  2. Felipe F., Bonet M.L., Ribot J., Palou A. Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes. 2004;53(4):882-89.
  3. Zhang M., Hu P., Krois C.R., Kane M.A., Napoli J.L. Altered vitamin A homeostasis and increased size and adiposity in the rdhl-null mouse. The FASEB Journal. 2007;21(11):2886-96.
  4. Ziouzenkova O., Orasanu G., Sharlach M., Akiyama T.E., Berger J.P., Viereck J., Hamilton J.A., Tang G., Dolnikowski G.G., Vogel S. Retinaldehyde represses adipogenesis and diet-induced obesity. Nature Medicine. 2007;13(6):695-702.
  5. Mercader J., Ribot J., Murano I., Felipe F., Cinti S., Bonet M.L., Palou A. Remodeling of white adipose tissue after retinoic acid administration in mice. Endocrinology. 2006;147(11):5325-32.
  6. Schug T.T., Berry D.C., Shaw N.S., Travis S.N., Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell. 2007;129(4):723-33.
  7. Schug T.T., Berry D.C., Toshkov I.A., Cheng L., Nikitin A.Y., Noy N. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR. Proceedings of the National Academy of Sciences. 2008;105(21):7546-51.
  8. Shaw N., Elholm M., Noy N. Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor β/δ. Journal of Biological Chemistry. 2003;278(43):41589-92.
  9. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., Boland R., Evans R.M. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proceedings of the National Academy of Sciences. 2002;99(1):303-08.
  10. Barish G.D., Narkar V.A., Evans R.M. PPARδ: a dagger in the heart of the metabolic syndrome. The Journal of Clinical Investigation. 2006;116(3):590-97.
  11. Lee C.-H., Olson P., Hevener A., Mehl I., Chong L.-W., Olefsky J.M., Gonzalez F.J., Ham J., Kang H., Peters J.M. PPARδ regulates glucose metabolism and insulin sensitivity. Proceedings of the National Academy of Sciences. 2006;103(9):3444-49.
  12. Gervois P., Torra I.P., Fruchart J.-C., Staels B. Regulation of lipid and lipoprotein metabolism by PPAR activators. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;38(1):3-11.
  13. Rabelo R., Reyes C., Schifman A., Silva J.E. A complex retinoic acid response element in the uncoupling protein gene defines a novel role for retinoids in thermogenesis. Endocrinology. 1996;137(8):3488-96.
  14. Rottman J.N., Widom R.L., Nadal-Ginard B., Mahdavi V., Karathanasis S.K. NOTES: a retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways. Molecular and Cellular Biology. 1991;11(7):3814-20.
  15. Zanotto-Filho A., Schröder R., Moreira J.C.F. Xanthine oxidase-dependent ROS production mediates vitamin A pro-oxidant effects in cultured Sertoli cells. Free Radical Research. 2008;42(6):593-601.
  16. Balbuena E., Milhem F., Kiremitci B.Z., Williams T.I., Collins L., Shu Q., Eroglu A. The biochemical effects of carotenoids in orange carrots on the colonic proteome in a mouse model of diet-induced obesity. Frontiers in Nutrition. 2024;11:1492380.
  17. Kaulmann A., Bohn T. Carotenoids, inflammation, and oxidative stress—implications of cellular signaling pathways and relation to chronic disease prevention. Nutrition Research. 2014;34(11):907-29.
  18. Fernández-Sánchez A., Madrigal-Santillán E., Bautista M., Esquivel-Soto J., Morales-González Á., Esquivel-Chirino C., Durante-Montiel I., Sánchez-Rivera G., Valadez-Vega C., Morales-González J.A. Inflammation, oxidative stress, and obesity. International Journal of Molecular Sciences. 2011;12(5):3117-32.
  19. Manna P., Jain S.K. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metabolic Syndrome and Related Disorders. 2015;13(10):423-44.
  20. Ellulu M.S., Patimah I., Khaza'ai H., Rahmat A., Abed Y. Obesity and inflammation: the linking mechanism and the complications. Archives of Medical Science. 2017;13(4):851-63.
  21. Bonet M.L., Canas J.A., Ribot J., Palou A. Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity. Archives of Biochemistry and Biophysics. 2015;572:112-25.
  22. Biehler E., Alkerwi A.A., Hoffmann L., Krause E., Guillaume M., Lair M.-L., Bohn T. Contribution of violaxanthin, neoxanthin, phytoene and phytofluene to total carotenoid intake: assessment in Luxembourg. Journal of Food Composition and Analysis. 2012;25(1):56-65.
  23. Baldrick F.R., Woodside J.V., Elborn J.S., Young I.S., McKinley M.C. Biomarkers of fruit and vegetable intake in human intervention studies: a systematic review. Critical Reviews in Food Science and Nutrition. 2011;51(9):795-815.
  24. Jing L., Xiao M., Dong H., Lin J., Chen G., Ling W., Chen Y. Serum carotenoids are inversely associated with RBP4 and other inflammatory markers in middle-aged and elderly adults. Nutrients. 2018;10(3):260.
  25. Eroglu A., Al’Abri I.S., Kopec R.E., Crook N., Bohn T. Carotenoids and their health benefits as derived via their interactions with gut microbiota. Advances in Nutrition. 2023;14(2):238-55.
  26. Ademowo O.S., Dias H.I., Pararasa C., Griffiths H.R. Nutritional hormesis in a modern environment. In: The science of hormesis in health and longevity. Elsevier; 2019. p. 75-86.
  27. Shin J., Song M.-H., Oh J.-W., Keum Y.-S., Saini R.K. Pro-oxidant actions of carotenoids in triggering apoptosis of cancer cells: a review of emerging evidence. Antioxidants. 2020;9(6):532.
  28. Tufail T., Bader Ul Ain H., Noreen S., Ikram A., Arshad M.T., Abdullahi M.A. Nutritional benefits of lycopene and beta-carotene: a comprehensive overview. Food Science & Nutrition. 2024;12(11):8715-41.
  29. Koubaa-Ghorbel F., Chaâbane M., Turki M., Makni-Ayadi F., El Feki A. The protective effects of Salvia officinalis essential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high-fat diet. Journal of Food Biochemistry. 2020;44(4):e13160.
  30. Hmidani A., Bourkhis B., Khouya T., Harnafi H., Filali-Zegzouti Y., Alem C. Effect of Phoenix dactylifera seeds (dates) extract in triton WR-1339 and high fat diet induced hyperlipidaemia in rats: a comparison with simvastatin. Journal of Ethnopharmacology. 2020;259:112961.
  31. Susilawati E., Sulaeman A., Muhsinin S., Levita J., Susilawati Y., Sumiwi S.A. Anti-obesity activity of Erythrina subumbrans (Hassk.) Merr leaves extract in high fructose-induced obesity in Wistar rats. Journal of Herbmed Pharmacology. 2024;13(1):120-28.
  32. Han G.-M., Soliman G.A., Meza J.L., Islam K.M., Watanabe-Galloway S. The influence of BMI on the association between serum lycopene and the metabolic syndrome. British Journal of Nutrition. 2016;115(7):1292-300.
  33. Luvizotto R.d.A.M., Nascimento A.F., Imaizumi E., Pierine D.T., Conde S.J., Correa C.R., Yeum K.-J., Ferreira A.L.A. Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats. British Journal of Nutrition. 2013;110(10):1803-09.
  34. Brito A.K.d.S., Lima G.d.M., Farias L.M.d., Rodrigues L.A.R.L., Carvalho V.B.L.d., Pereira C.F.d.C., Frota K.d.M.G., Conde-Júnior A.M., Silva A.M.O., Rizzo M.d.S. Lycopene-rich extract from red guava (Psidium guajava L.) decreases plasma triglycerides and improves oxidative stress biomarkers on experimentally-induced dyslipidemia in hamsters. Nutrients. 2019;11(2):393.
  35. Zeng Z., He W., Jia Z., Hao S. Lycopene improves insulin sensitivity through inhibition of STAT3/Srebp-1c-mediated lipid accumulation and inflammation in mice fed a high-fat diet. Experimental and Clinical Endocrinology & Diabetes. 2017;125(9):610-17.

 

  1. Róvero Costa M., Leite Garcia J., Cristina Vágula de Almeida Silva C., Junio Togneri Ferron A., Valentini Francisqueti-Ferron F., Kurokawa Hasimoto F., Schmitt Gregolin C., Henrique Salomé de Campos D., Roberto de Andrade C., dos Anjos Ferreira A.L. Lycopene modulates pathophysiological processes of non-alcoholic fatty liver disease in obese rats. Antioxidants. 2019;8(8):276.
  2. Guerendiain M., Mayneris-Perxachs J., Montes R., López-Belmonte G., Martín-Matillas M., Castellote A.I., Martín-Bautista E., Martí A., Martínez J.A., Moreno L. Relation between plasma antioxidant vitamin levels, adiposity and cardio-metabolic profile in adolescents: effects of a multidisciplinary obesity programme. Clinical Nutrition. 2017;36(1):209-17.
  3. Takahashi S., Waki N., Mohri S., Takahashi H., Ara T., Aizawa K., Suganuma H., Kawada T., Goto T. Apo-12′-lycopenal, a lycopene metabolite, promotes adipocyte differentiation via peroxisome proliferator-activated receptor γ activation. Journal of Agricultural and Food Chemistry. 2018;66(50):13152-61.
  4. Warnke I., Jocken J.W., Schoop R., Toepfer C., Goralczyk R., Schwager J. Combinations of bio-active dietary constituents affect human white adipocyte function in vitro. Nutrition & Metabolism. 2016;13:1-10.
  5. Kosmas C.E., Martinez I., Sourlas A., Bouza K.V., Campos F.N., Torres V., Montan P.D., Guzman E. High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;7.
  6. Fenni S., Hammou H., Astier J., Bonnet L., Karkeni E., Couturier C., Tourniaire F., Landrier J.F. Lycopene and tomato powder supplementation similarly inhibit high-fat diet induced obesity, inflammatory response, and associated metabolic disorders. Molecular Nutrition & Food Research. 2017;61(9):1601083.
  7. Luvizotto R.d.A.M., Nascimento A.F., Imaizumi E., Pierine D.T., Conde S.J., Correa C.R., Yeum K.-J., Ferreira A.L.A. Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats. British Journal of Nutrition. 2013;110(10):1803-09.
  8. Kassab R.B., Lokman M.S., Daabo H.M., Gaber D.A., Habotta O.A., Hafez M.M., Zhery A.S., Moneim A.E.A., Fouda M.S. Ferulic acid influences Nrf2 activation to restore testicular tissue from cadmium-induced oxidative challenge, inflammation, and apoptosis in rats. Journal of Food Biochemistry. 2020;44(12):e13505.
  9. El-Khadragy M.F., Al-Megrin W.A., Alomar S., Alkhuriji A.F., Metwally D.M., Mahgoub S., Amin H.K., Habotta O.A., Moneim A.E.A., Albeltagy R.S. Chlorogenic acid abates male reproductive dysfunction in arsenic-exposed mice via attenuation of testicular oxido-inflammatory stress and apoptotic responses. Chemico-Biological Interactions. 2021;333:109333.
  10. Yeh S.-L., Hu M.-L. Antioxidant and pro-oxidant effects of lycopene in comparison with β-carotene on oxidant-induced damage in Hs68 cells. The Journal of Nutritional Biochemistry. 2000;11(11-12):548-54.
  11. Jomova K., Lawson M., Gala L. Prooxidant effect of lycopene on triglyceride oxidation. The Journal of Microbiology, Biotechnology and Food Sciences. 2012;1:942.
  12. Jeganathan B., Punyasiri P.N., Kottawa-Arachchi J.D., Ranatunga M.A., Abeysinghe I.S.B., Gunasekare M.K., Bandara B.R. Genetic variation of flavonols quercetin, myricetin, and kaempferol in the Sri Lankan tea (Camellia sinensis L.) and their health-promoting aspects. International Journal of Food Science. 2016;2016(1):6057434.
  13. Pikulski M., Brodbelt J.S. Differentiation of flavonoid glycoside isomers by using metal complexation and electrospray ionization mass spectrometry. Journal of the American Society for Mass Spectrometry. 2003;14(12):1437-53.
  14. Cabanlit K.L., Torres M.A.J., Demayo C.G. Ficus spp. (Figs) and their anticancer potential: a systematic review of laboratory studies and traditional uses in the Philippines. Journal of Herbmed Pharmacology. 2025;14(2):133-52.
  15. Puangploy P., Kittipongpittaya K., Khoontawad J., Jorjong S., Phalangsuk N., Phansuwan T., Senngam P., Boonpul O., Lertsit K., Sooksabine K. Phytochemical screening, total phenolics, total flavonoids, total tannins, antioxidant activities, and α-glucosidase inhibition of ethanolic leaf extracts from 37 cultivars of Antidesma puncticulatum Miq. Journal of Herbmed Pharmacology. 2024;13(1):61-73.
  16. Rahimi-Madiseh M., Heidarian E., Kheiri S., Rafieian-Kopaei M. Effect of hydroalcoholic Allium ampeloprasum extract on oxidative stress, diabetes mellitus and dyslipidemia in alloxan-induced diabetic rats. Biomedicine & Pharmacotherapy. 2017;86:363-67.
  17. Gaur R.C., Kanta C. A critical review of antioxidant potential and pharmacological applications of important Ficus species. Journal of Herbmed Pharmacology. 2024;13(4):537-49.
  18. Gopal M., Gangaraja S., Shivakumar A.G., Lokesh P., Rangaswamy N., Devaraju S.G.H., Shashidhar B., Sanjay S. Phytochemical, pharmacognostic, and in silico investigation of the anti-diabetic potential of Elaeocarpus angustifolius seeds. Journal of Herbmed Pharmacology. 2025;14(4):435-46.
  19. Wang S., Wu D., Matthan N.R., Lamon-Fava S., Lecker J.L., Lichtenstein A.H. Enhanced aortic macrophage lipid accumulation and inflammatory response in LDL receptor null mice fed an atherogenic diet. Lipids. 2010;45:701-11.
  20. Zhang N., Huan Y., Huang H., Song G.-M., Sun S.-J., Shen Z.-F. Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate. Acta Pharmacologica Sinica. 2010;31(1):35-42.
  21. Ling Y., Shi Z., Yang X., Cai Z., Wang L., Wu X., Ye A., Jiang J. Hypolipidemic effect of pure total flavonoids from peel of Citrus (PTFC) on hamsters of hyperlipidemia and its potential mechanism. Experimental Gerontology. 2020;130:110786.
  22. Eghbaliferiz S., Iranshahi M. Prooxidant activity of polyphenols, flavonoids, anthocyanins and carotenoids: updated review of mechanisms and catalyzing metals. Phytotherapy Research. 2016;30(9):1379-91.
  23. Procházková D., Boušová I., Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011;82(4):513-23.
  24. Lopes F., Cunha N., de Campos B., Fattori V., Panis C., Cecchini R., Verri Jr., Pinge-Filho P., Martins-Pinge M. Antioxidant therapy reverses sympathetic dysfunction, oxidative stress, and hypertension in male hyperadipose rats. Life Sciences. 2022;295:120405.
  25. Luo J., le Cessie S., van Heemst D., Noordam R.J. Diet-derived circulating antioxidants and risk of coronary heart disease: a Mendelian randomization study. Journal of the American College of Cardiology. 2021;77(1):45-54.
  26. Ziegler M., Wallert M., Lorkowski S. Antioxidants. Antioxidants. 2020;9(10):935.
  27. Yu L., Wang Y., Yu D., Zhang S., Zheng F., Ding N., Zhu L., Zhu Q., Sun W., Li S. Association between serum vitamin A, blood lipid level and dyslipidemia among Chinese children and adolescents. Nutrients. 2022;14(7):1444.
  28. Yang F.-C., Xu F., Wang T.-N., Chen G.-X. Roles of vitamin A in the regulation of fatty acid synthesis. World Journal of Clinical Cases. 2021;9(18):4506.
  29. Gholizadeh M., Basafa Roodi P., Abaj F., Shab-Bidar S., Saedisomeolia A., Asbaghi O., Lak M.J. Influence of vitamin A supplementation on inflammatory biomarkers in adults: A systematic review and meta-analysis of randomized clinical trials. Scientific Reports. 2022;12(1):21384.
  30. Tamura I., Sakaki T., Nishikawa T., Kakudo K., Tanaka A., Shioji I. Influence of vitamin A deficiency on the expression of cytokeratin in the rat sublingual gland. Journal of Osaka Dental University. 2001;35(1):35-41.
  31. Rychter A.M., Hryhorowicz S., Słomski R., Dobrowolska A., Krela-Kaźmierczak I. Antioxidant effects of vitamin E and risk of cardiovascular disease in women with obesity–A narrative review. Clinical Nutrition. 2022;41(7):1557-65.
  32. Winckler K., Tarnow L., Lundby-Christensen L., Almdal T.P., Wiinberg N., Eiken P., Boesgaard T.W. Vitamin D, carotid intima–media thickness and bone structure in patients with type 2 diabetes. Endocrine Connections. 2015;4(2):128-35.
  33. Sun H., Long S.R., Li X., Ge H., Liu X., Wang T., Yu F., Wang Y., Xue Y., Li W. Serum vitamin D deficiency and vitamin D receptor gene polymorphism are associated with increased risk of cardiovascular disease in a Chinese rural population. Nutrition Research. 2019;61:13-21.
  34. Wang S., Wang J., Zhang R., Wang T., Yan D., He Z., Jiang F., Hu C., Jia W. Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients. Cardiovascular Diabetology. 2018;17:1-11.
  35. Miller D., Hayes K. Vitamin excess and toxicity. Nutritional Toxicology. 1982;1:81-133.
  36. Niki E., Traber M.G. A history of vitamin E. Annals of Nutrition and Metabolism. 2012;61(3):207-12.
  37. Mahou Y., Jaafar D.M.B., Al Moudani N., Jeddi M., Chda A., Fettoukh N., Benbrahim K.F., Aarab L., El Bouri A., Stambouli H. Chemical profile and bioactive properties of Cannabis sativa threshing residue: Vasorelaxant, antioxidant, immunomodulatory, and antibacterial activities. Journal of Herbmed Pharmacology. 2024;14(1):29-42.
  38. Onni A.T., Balakrishna R., Perillo M., Amato M., Arjmand E.J., Thomassen L.M., Lorenzini A., Fadnes L.T. Umbrella review of systematic reviews and meta-analyses on consumption of different food groups and risk of all-cause mortality. Advances in Nutrition. 2025:100393.
  39. Müller A., Most E., Pallauf J. Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic db/db mice. Journal of Animal Physiology and Animal Nutrition. 2005;89(3-6):94-104.
  40. Wang C., Li J., Lv X., Zhang M., Song Y., Chen L., Liu Y. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. European Journal of Pharmacology. 2009;620(1-3):131-37.
  41. Xu T.J., Yuan B.X., Zou Y.M., Zang W.J. The effect of insulin in combination with selenium on blood glucose and GLUT4 expression in the cardiac muscle of streptozotocin-induced diabetic rats. Fundamental & Clinical Pharmacology. 2010;24(2):199-204.
  42. Olukman M., Orhan C.E., Çelenk F.G., Ülker S. Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions. Journal of Diabetes and Its Complications. 2010;24(6):415-23.
  43. Oztürk Z., Gurpinar T., Vural K., Boyacıoglu S., Korkmaz M., Var A.B. Effects of selenium on endothelial dysfunction and metabolic profile in low dose streptozotocin induced diabetic rats fed a high fat diet. Biotechnic & Histochemistry. 2015;90(7):506-15.
  44. Hwang J., Kleinhenz D.J., Rupnow H.L., Campbell A.G., Thulé P.M., Sutliff R.L., Hart C.M. The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vascular Pharmacology. 2007;46(6):456-62.
  45. Frey R.S., Ushio–Fukai M., Malik A.B. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxidants & Redox Signaling. 2009;11(4):791-810.
  46. Cosentino-Gomes D., Rocco-Machado N., Meyer-Fernandes J.R. Cell signaling through protein kinase C oxidation and activation. International Journal of Molecular Sciences. 2012;13(9):10697-721.
  47. Ali M.S., Hussein R.M., Kandeil M.A. The pro-oxidant, apoptotic and anti-angiogenic effects of selenium supplementation on colorectal tumors induced by 1,2-dimethylhydrazine in BALB/C mice. Reports in Biochemistry & Molecular Biology. 2019;8(3):216.
  48. Kuršvietienė L., Mongirdienė A., Bernatonienė J., Šulinskienė J., Stanevičienė I. Selenium anticancer properties and impact on cellular redox status. Antioxidants. 2020;9(1):80.
  49. Xu Y., Liu J., Han E., Wang Y., Gao J. Efficacy of coenzyme Q10 in patients with chronic kidney disease: Protocol for a systematic review. BMJ Open. 2019;9(5):e029053.
  50. Singh U., Devaraj S., Jialal I. Coenzyme Q10 supplementation and heart failure. Nutrition Reviews. 2007;65(6):286-93.
  51. Mortensen S.A. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of “Q-symbio”—A multinational trial. Biofactors. 2003;18(1-4):79-89.
  52. Shen Q., Pierce J.D. Supplementation of coenzyme Q10 among patients with type 2 diabetes mellitus. Healthcare. 2015;3(2):296-309.
  53. Sharifi N., Tabrizi R., Moosazadeh M., Mirhosseini N., Lankarani K.B., Akbari M., Chamani M., Kolahdooz F., Asemi Z. The effects of coenzyme Q10 supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Current Pharmaceutical Design. 2018;24(23):2729-42.
  54. Sahebkar A., Simental-Mendía L.E., Stefanutti C., Pirro M. Supplementation with coenzyme Q10 reduces plasma lipoprotein (a) concentrations but not other lipid indices: a systematic review and meta-analysis. Pharmacological Research. 2016;105:198-209.

 

  1. Suksomboon N., Poolsup N., Juanak N. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics. 2015;40(4):413-18.
  2. Tekin Y.B., Tumkaya L., Mercantepe T., Topal Z.S., Samanci T.C., Yilmaz H.K., Rakici S., Topcu A. Evaluation of the protective effect of coenzyme Q10 against x-ray irradiation-induced ovarian injury. Journal of Obstetrics and Gynaecology Research. 2024;50(7):1242-49.
  3. Silva S.V.e., Gallia M.C., Luz J.R.D.d., Rezende A.A.d., Bongiovanni G.A., Araujo-Silva G., Almeida M.d.G. Antioxidant effect of coenzyme Q10 in the prevention of oxidative stress in arsenic-treated CHO-K1 cells and possible participation of zinc as a pro-oxidant agent. Nutrients. 2022;14(16):3265.
  4. Azami S., Forouzanfar F. Therapeutic potentialities of green tea (Camellia sinensis) in ischemic stroke: Biochemical and molecular evidence. Metabolic Brain Disease. 2024;39(2):347-57.
  5. Morrison M., van der Heijden R., Heeringa P., Kaijzel E., Verschuren L., Blomhoff R., Kooistra T., Kleemann R. Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo. Atherosclerosis. 2014;233(1):149-56.
  6. Gutiérrez-Salmeán G., De Jesús-Torres E., Ortiz-Vilchis P., Vacaseydel C., Garduño-Siciliano L. Cardiometabolic alterations in Wistar rats induced by an obesogenic Paigen-like diet: effects of (-) epicatechin. Journal of Diabetes & Metabolism. 2014;5(430):2.
  7. Xiong M., Jia C., Cui J., Wang P., Du X., Yang Q., Zhu Y., Wang W., Zhang T., Chen Y. Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model. Journal of Ethnopharmacology. 2015;159:84-92.
  8. Shaki F., Shayeste Y., Karami M., Akbari E., Rezaei M., Ataee R. The effect of epicatechin on oxidative stress and mitochondrial damage induced by homocysteine using isolated rat hippocampus mitochondria. Research in Pharmaceutical Sciences. 2017;12(2):119-27.
  9. Czernichow S., Vergnaud A.-C., Galan P., Arnaud J., Favier A., Faure H., Huxley R., Hercberg S., Ahluwalia N. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. American Journal of Clinical Nutrition. 2009;90(2):329-35.
  10. Park Y., Spiegelman D., Hunter D.J., Albanes D., Bergkvist L., Buring J.E., Freudenheim J.L., Giovannucci E., Goldbohm R.A., Harnack L. Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes & Control. 2010;21:1745-57.
  11. Hercberg S., Galan P., Preziosi P., Bertrais S., Mennen L., Malvy D., Roussel A.-M., Favier A., Briançon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine. 2004;164(21):2335-42.
  12. González M.J., Miranda-Massari J.R., Mora E.M., Guzmán A., Riordan N.H., Riordan H.D., Casciari J.J., Jackson J.A., Román-Franco A. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integrative Cancer Therapies. 2005;4(1):32-44.
  13. Lätsch A., Blaurock-Busch E., Eisenmann-Klein M. Increased levels of transition metals in breast cancer tissue. Neuro Endocrinology Letters. 2006;27:1.
  14. Urbański N., Beręsewicz A. Generation of •OH initiated by interaction of Fe²⁺ and Cu⁺ with dioxygen; comparison with the Fenton chemistry. Acta Biochimica Polonica. 2000;47(4):951-62.
  15. Asplund K.U., Jansson P.J., Lindqvist C., Nordström T. Measurement of ascorbic acid (vitamin C) induced hydroxyl radical generation in household drinking water. Free Radical Research. 2002;36(12):1271-76.
  16. Mathews S., Kumar R., Solioz M. Copper reduction and contact killing of bacteria by iron surfaces. Applied and Environmental Microbiology. 2015;81(18):6399-403.
  17. Duarte T.L., Lunec J. When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C. Free Radical Research. 2005;39(7):671-86.
  18. Podmore I.D., Griffiths H.R., Herbert K.E., Mistry N., Mistry P., Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 1998;392(6676):559-59
  19. Carlisle D., Pritchard D., Singh J., Owens B., Blankenship L., Orenstein J., Patierno S. Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. Toxicological Sciences. 2000;55(1):60-68.
  20. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297(8):842-57.
  21. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Archives of Biochemistry and Biophysics. 2008;476(2):107-12.
  22. Terpinc P., Polak T., Šegatin N., Hanzlowsky A., Ulrih N.P., Abramovič H. Antioxidant properties of 4-vinyl derivatives of hydroxycinnamic acids. Food Chemistry. 2011;128(1):62-69.
  23. Yordi E.G., Pérez E.M., Matos M.J., Villares E.U. Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence. Nutrition, Well-Being and Health. 2012;2:23-48.
  24. Han M.H., Kim H.J., Jeong J.-W., Park C., Kim B.W., Choi Y.H. Inhibition of adipocyte differentiation by anthocyanins isolated from the fruit of Vitis coignetiae Pulliat is associated with the activation of AMPK signaling pathway. Toxicology Research. 2018;34:13-21.
  25. Huang W., Yan Z., Li D., Ma Y., Zhou J., Sui Z. Antioxidant and anti-inflammatory effects of blueberry anthocyanins on high glucose-induced human retinal capillary endothelial cells. Oxidative Medicine and Cellular Longevity. 2018;2018:1862462.
  26. Suantawee T., Elazab S.T., Hsu W.H., Yao S., Cheng H., Adisakwattana S. Cyanidin stimulates insulin secretion and pancreatic β-cell gene expression through activation of L-type voltage-dependent Ca²⁺ channels. Nutrients. 2017;9(8):814.
  27. Kongthitilerd P., Thilavech T., Marnpae M., Rong W., Yao S., Adisakwattana S., Cheng H., Suantawee T. Cyanidin-3-rutinoside stimulated insulin secretion through activation of L-type voltage-dependent Ca²⁺ channels and the PLC-IP₃ pathway in pancreatic β-cells. Biomedicine & Pharmacotherapy. 2022;146:112494.
  28. Wu T., Gao Y., Guo X., Zhang M., Gong L. Blackberry and blueberry anthocyanin supplementation counteract high-fat-diet-induced obesity by alleviating oxidative stress and inflammation and accelerating energy expenditure. Oxidative Medicine and Cellular Longevity. 2018;2018:4051232.
  29. Zhang H., Xu Z., Zhao H., Wang X., Pang J., Li Q., Yang Y., Ling W. Anthocyanin supplementation improves anti-oxidative and anti-inflammatory capacity in a dose–response manner in subjects with dyslipidemia. Redox Biology. 2020;32:101474.
  30. Ahmad M., Sultana M., Raina R., Pankaj N.K., Verma P.K., Prawez S. Hypoglycemic, hypolipidemic, and wound healing potential of quercetin in streptozotocin-induced diabetic rats. Pharmacognosy Magazine. 2017;13(Suppl 3):S633.
  31. Han Y., Wu J.-Z., Shen J.-Z., Chen L., He T., Jin M.-W., Liu H. Pentamethylquercetin induces adipose browning and exerts beneficial effects in 3T3-L1 adipocytes and high-fat diet-fed mice. Scientific Reports. 2017;7:1123.
  32. Zhang M., Hu P., Krois C.R., Kane M.A., Napoli J.L. Altered vitamin A homeostasis and increased size and adiposity in the rdhl-null mouse. FASEB Journal. 2007;21(11):2886–2896.
  33. Ferguson B.S., Nam H., Morrison R.F. Curcumin inhibits 3T3-L1 preadipocyte proliferation by mechanisms involving post-transcriptional p27 regulation. Bioscience Reports. 2016;36(1):e00349.
  34. Zhao D., Pan Y., Yu N., Bai Y., Ma R., Mo F., Zuo J., Chen B., Jia Q., Zhang D. Curcumin improves adipocytes browning and mitochondrial function in 3T3-L1 cells and obese rodent model. Royal Society Open Science. 2021;8(3):200974.
  35. Torabi S., DiMarco N.M. Polyphenols extracted from grape powder induce lipogenesis and glucose uptake during differentiation of murine preadipocytes. Experimental Biology and Medicine. 2016;241(16):1776–1785.
  36. Yoshitomi R., Yamamoto M., Kumazoe M., Fujimura Y., Yonekura M., Shimamoto Y., Nakasone A., Kondo S., Hattori H., Haseda A. The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: A randomized placebo-controlled clinical trial. Scientific Reports. 2021;11:19067.
  37. Żary-Sikorska E., Fotschki B., Jurgoński A., Kosmala M., Milala J., Kołodziejczyk K., Majewski M., Ognik K., Juśkiewicz J. Protective effects of a strawberry ellagitannin-rich extract against pro-oxidative and pro-inflammatory dysfunctions induced by a high-fat diet in a rat model. Molecules. 2020;25(24):5874.
  38. de Sousa G.M., Cazarin C.B.B., Junior M.R.M., de Almeida Lamas C., Quitete V.H.A.C., Pastore G.M., Bicas J.L. The effect of α-terpineol enantiomers on biomarkers of rats fed a high-fat diet. Heliyon. 2020;6(4):e03725.
  39. Shidfar F., Rezaei K., Hosseini Esfahani S., Heydari I. The effects of vitamin E on insulin resistance and cardiovascular disease risk factors in metabolic syndrome. International Journal of Endocrinology and Metabolism. 2009;10(5):445–454.
  40. Safari M., Ani M., Naderi G., Asgari S. The effect of volatile essences and vitamin C on LDL tendency to its receptor for prevention of atherosclerosis. Avicenna Journal of Clinical Medicine. 2001;4:32–36.
  41. Aghasi M., Shidfar F., Vafa M., Haydari I., Haggani H. The effect of concurrent zinc-vitamin A supplementation on serum lipoproteins, apolipoproteins A-1 and B, and glycemic indices in type 1 diabetes mellitus patients. International Journal of Food Sciences and Nutrition. 2008;59(2):63–71.
  42. Cerhan J.R., Saag K.G., Merlino L.A., Mikuls T.R., Criswell L.A. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. American Journal of Epidemiology. 2003;157(4):345–354.
  43. Evans P., Halliwell B. Micronutrients: oxidant/antioxidant status. British Journal of Nutrition. 2001;85(S2):S67–S74.
  44. Zhu R., Wei J., Liu H., Liu C., Wang L., Chen B., Li L., Jia Q., Tian Y., Li R. Lycopene attenuates body weight gain through induction of browning via regulation of peroxisome proliferator-activated receptor γ in high-fat diet-induced obese mice. Journal of Nutritional Biochemistry. 2020;78:108335.
  45. Esterbauer H., Gebicki J., Puhl H., Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biology and Medicine. 1992;13(4):341–390.
  46. Sadiya A., Ahmed S.M., Carlsson M., Tesfa Y., George M., Ali S.H., Siddieg H.H., Abusnana S. Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial. Clinical Nutrition. 2016;35(1):77–82.
  47. Li H., Xu Q.-Y., Xie Y., Luo J.-J., Cao H.-X., Pan Q. Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis. Annals of Hepatology. 2021;24:100316.
  48. Hajizadeh-Sharafabad F., Tarighat-Esfanjani A., Ghoreishi Z., Sarreshtedari M. Lutein supplementation combined with a low-calorie diet in middle-aged obese individuals: Effects on anthropometric indices, body composition and metabolic parameters. British Journal of Nutrition. 2021;126(7):1028–1039.
  49. Pourrajab B., Sharifi-Zahabi E., Soltani S., Shahinfar H., Shidfar F. Comparison of canola oil and olive oil consumption on the serum lipid profile in adults: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition. 2023;63(33):12270–12284.
  50. Ghosh A., Bhattacharjee I., Chandra G. Hypolipidemic effect of steroid compound from Cestrum diurnum (Solanaceae: Solanales) in normocholesterolemic albino rat. Natural Product Research. 2019;33(4):573–576.
  51. Li C., Fang B., Wei Y., Mo R., Lin X., Huang Q. The regulatory mechanism of Smilax china L. saponins against nonalcoholic fatty liver is revealed by metabolomics and transcriptomics. Journal of Oleo Science. 2024;73(5):695–708.